Drug intelligence / Profile preview

Natal DHA

Development stage
Unknown
Lead developer
Trigen Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

Natal DHA is a prescription-strength prenatal and postnatal multivitamin and mineral supplement that includes docosahexaenoic acid (DHA), an omega-3 fatty acid. Developed and marketed by Trigen Laboratory, it is designed to provide comprehensive nutritional support for women during pregnancy and the postpartum period, including lactation. The formulation typically contains essential nutrients such as folic acid, which is critical for DNA synthesis and the prevention of neural tube defects; iron, which supports increased maternal blood volume and fetal oxygenation; and DHA, which is a primary structural component of the fetal brain and retina. As a prescription product, it is formulated to meet specific therapeutic levels of vitamins and minerals that may exceed standard over-the-counter dietary supplement concentrations.

Brand names
Natal DHAComplete Natal DHA
Other names
prenatal multivitamins + docosahexaenoic acidprescription prenatal vitamins with DHA
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on Natal DHA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natal DHA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call